Imunon Inc (IMNN)

Name: Imunon Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$0.0

Net Income

-$4.2B

Operating Margin

N/A

Free Cash Flow

-$18.9M

Debt / Assets

56.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Imunon Inc (IMNN).
Income Statement (Quarterly)	2026-03-31	2025-03-31	2024-12-31	2024-09-30
Revenue	0	0	0	0
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,969,244,000	1,980,207	1,913,486	1,668,258
Operating Expenses	4,306,552,000	4,145,299	4,146,182	4,961,467
Operating Income	-4,306,552,000	-4,145,299	-4,146,182	-4,961,467
Interest Expense	0	0	0	0
Income Before Tax	-4,249,022,000	-4,102,495	-4,057,225	-4,845,475
Income Tax Expense	0	0	0	0
Net Income	-4,249,022,000	-4,102,495	-4,057,225	-4,845,475
Per Share
EPS	-0.84	-0.28	-0.35	-0.34
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Imunon Inc (IMNN).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	0	0	0	500,000	500,000
Cost of Revenue	0	0	0	731,629	0
Gross Profit	0	0	0	-231,629	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	6,869,996	7,493,035	9,742,739	13,688,000	10,887,903
Operating Expenses	14,650,694	19,132,446	21,030,430	25,422,000	21,507,190
Operating Income	-14,650,694	-19,132,446	-21,030,430	-24,922,000	-21,007,190
Interest Expense	0	0	197,080	4,573,000	569,881
Income Before Tax	-14,495,028	-18,620,242	-20,795,362	-37,465,000	-22,152,696
Income Tax Expense	0	0	0	-1,567,000	-1,383,446
Net Income	-14,495,000	-18,620,242	-19,514,977	-35,898,000	-20,769,250
Per Share
EPS	-6.83	-1.72	-10.25	-5.03	-3.83
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Imunon Inc (IMNN).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	5,872,767	5,838,566	11,493,000	19,586,272
Short Term Investments	0	9,857,087	21,384,000	29,803,095
Net Receivables	0	0	128,932	108,844
Inventory	0	0	1,370,635	0
Total Current Assets	8,008,959	18,240,704	37,155,000	51,945,624
Property Plant Equipment	1,658,405	2,346,980	754,000	1,168,006
Goodwill and Intangibles	0	0	0	13,366,234
Total Assets	9,717,364	21,918,069	43,976,000	74,046,799
Liabilities
Account Payables	1,300,026	3,515,192	8,381,000	2,547,251
Short Term Debt	452,358	485,421	1,656,000	548,870
Total Current Liabilities	4,786,131	7,391,134	10,037,000	6,769,658
Long Term Debt	686,935	1,139,293	4,611,000	6,085,210
Total Liabilities	5,473,066	8,530,427	14,648,000	18,250,868
Shareholders Equity
Retained Earnings	-406,803,044	-388,182,802	-368,668,000	-332,769,591
Total Shareholders Equity	4,244,298	13,387,642	29,328,000	55,795,931

Balance sheet annual history for Imunon Inc (IMNN).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	5,872,767	5,838,566	11,493,000	19,586,272	17,164,177
Short Term Investments	0	9,857,087	21,384,000	29,803,095	0
Net Receivables	0	0	128,932	108,844	0
Inventory	0	0	1,370,635	0	0
Total Current Assets	8,008,959	18,240,704	37,155,000	51,945,624	18,824,872
Property Plant Equipment	1,658,405	2,346,980	754,000	1,168,006	1,341,887
Goodwill and Intangibles	0	0	0	13,366,234	15,455,995
Total Assets	9,717,364	21,918,069	43,976,000	74,046,799	37,527,338
Liabilities
Account Payables	1,300,026	3,515,192	8,381,000	2,547,251	2,244,847
Short Term Debt	452,358	485,421	1,656,000	548,870	1,550,076
Total Current Liabilities	4,786,131	7,391,134	10,037,000	6,769,658	6,753,455
Long Term Debt	686,935	1,139,293	4,611,000	6,085,210	3,934,497
Total Liabilities	5,473,066	8,530,427	14,648,000	18,250,868	18,916,257
Shareholders Equity
Retained Earnings	-406,803,044	-388,182,802	-368,668,000	-332,769,591	-312,000,341
Total Shareholders Equity	4,244,298	13,387,642	29,328,000	55,795,931	18,611,081

Cash flow quarterly history for Imunon Inc (IMNN).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-18,620,242	-19,514,977	-35,898,234	-20,769,250
Depreciation & Amortization	718,116	720,005	731,629	702,918
Stock Based Compensation	477,256	800,000	2,673,034	3,759,737
Change in Working Capital	-2,648,502	-2,066,412	1,210,702	-970,744
Operating Cash Flow	-18,854,970	-19,022,148	-23,131,376	-16,223,603
Investing Activities
Capital Expenditure	-29,541	-451,759	-267,800	-311,613
Investments	-29,541	-451,759	-267,800	-311,613
Investing Cash Flow	9,828,733	11,006,435	8,315,278	-30,122,682
Financing Activities
Debt Repayment	0	-6,420,000	0	-5,190,587
Common Stock Issued/Repurchased	9,060,438	2,781,438	-21,777,333	52,688,946
Dividends Paid	0	0	0	0
Financing Cash Flow	9,060,438	-3,638,562	6,722,667	54,768,380
Summary
Free Cash Flow	-18,884,511	-19,473,907	-23,399,176	-16,535,216
Net Change in Cash	34,201	-7,154,275	-8,093,431	8,422,095

Cash flow annual history for Imunon Inc (IMNN).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-18,620,242	-19,514,977	-35,898,234	-20,769,250	-21,483,561
Depreciation & Amortization	718,116	720,005	731,629	702,918	741,524
Stock Based Compensation	477,256	800,000	2,673,034	3,759,737	1,851,391
Change in Working Capital	-2,648,502	-2,066,412	1,210,702	-970,744	-864,360
Operating Cash Flow	-18,854,970	-19,022,148	-23,131,376	-16,223,603	-15,618,676
Investing Activities
Capital Expenditure	-29,541	-451,759	-267,800	-311,613	-19,092
Investments	-29,541	-451,759	-267,800	-311,613	-19,092
Investing Cash Flow	9,828,733	11,006,435	8,315,278	-30,122,682	7,924,016
Financing Activities
Debt Repayment	0	-6,420,000	0	-5,190,587	-6,524,750
Common Stock Issued/Repurchased	9,060,438	2,781,438	-21,777,333	52,688,946	22,811,669
Dividends Paid	0	0	0	0	0
Financing Cash Flow	9,060,438	-3,638,562	6,722,667	54,768,380	17,983,564
Summary
Free Cash Flow	-18,884,511	-19,473,907	-23,399,176	-16,535,216	-15,637,768
Net Change in Cash	34,201	-7,154,275	-8,093,431	8,422,095	10,288,904